Papers

1

Total Citations

11

H-Index

1

About

Yi An is a rising computational chemist whose work sits at the intersection of drug discovery and artificial intelligence. His primary research focus is the development of innovative in silico methods to identify chemical probes for challenging, “undruggable” protein targets. An’s most notable contribution is the creation of FRASE-bot (FRagment-based hit-finding robot), a novel computational platform that integrates fragment-based screening with machine learning to accelerate the discovery of small-molecule inhibitors. In a landmark 2024 study, he applied FRASE-bot to successfully identify CIB1-directed anti-tumor agents, demonstrating the platform’s power to uncover hits against proteins lacking known ligands. This work, already garnering 11 citations in its first year, has been recognized for its potential to transform early-stage drug discovery by dramatically reducing the time and cost of hit identification. An’s research is particularly impactful for students and researchers interested in the convergence of cheminformatics, structural biology, and AI, offering a practical blueprint for tackling some of the most stubborn targets in oncology and beyond.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot
11 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: University of North Carolina at Chapel Hill

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago